AHB-137 Clinical Trials

3 actively recruiting trials

▲ +1 trial since May 2026

Pipeline

Phase 2: 3

Top Sponsors

Ausper Biopharma Co., Ltd.2
AusperBio Therapeutics Inc.1

Indications

Liver Disease3
Chronic Hepatitis b2
Hepatitis B, Chronic1

Other3 trials

A Multicenter Study of AHB-137 Injection Combined With Other Hepatitis B Drugs

Phase 2

A Study to Evaluate the Efficacy and Safety of AHB-137 Injection in Participants With Chronic Hepatitis B (CHB)

Phase 2

Phase 2 Study of AHB-137 in HBeAg Negative Chronic Hepatitis B (CHB) Participants in Asia Pacific Region

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.